About DoAI
OUR MISSION
Enabling human to live free life from diseasethrough the medical revolution based on AI technology.
OUR VISION
Realizing AI-based early diagnosis of cancer andpersonalized precision medical care.
2020
+ TIPS R&D Project selected
+ Korea Health Industry Development Institute project selected
+ Korea Credit Guarantee Fund <FIRST PENGUIN COMPANY> selected
+ $1.3M investment by Korea Credit Guarantee Fund
+ Korea Institute for Advancement of Technology <BIG3 Innovative Growth Support Project> selected
+ Korea Institute of Start-up and Entrepreneurship Development <Challenge! K-Startup 2020 AI League> advanced to the finals
2019
+ DoAI R&D Center accredited
+ Ministry of Health and Welfare & Asan Hospital chanllenge award : 2nd rank
+ Joint research project with SNUH
+ KOICA CTS project selected
+ Joint research contract signed with Asan Hospital
+ Joint research contract signed with GC Labs
+ Joint research project with CAU
+ $0.6M investment by GC Holdings
2018
+ DoAI Inc. founded
+ $1.8M investment by GC Holdings
+ MOU with University Medical Center (UMC) in Ho chi minh, Vietnam
+ Joint research contract signed with GC Genome : NIPT
Leadership
Michael Yong Choi / 최용준
Chief Executive Officer
Do Synho / 도신호
Scientific Advisor
Moon Hanlim / 문한림
Chief Medical Officer, VP
Jwa-Min Nam / 남좌민
Domain Chief Technology Officer
Lee Jungho / 이정호
Chief Operating Officer, VP
Advisors
Yoon Sungroh / 윤성로
Advisor
Moon Youngwan / 문영완
Advisor
Steve Chai / 채수일
Adviser